2026年8月20日 美国东部时间13:04 / 哥伦比亚广播公司新闻
作者：玛丽·坎宁安
玛丽·坎宁安是哥伦比亚广播公司MoneyWatch栏目的记者。她曾就职于《60分钟》、哥伦比亚广播公司新闻网以及哥伦比亚广播公司24小时新闻频道，为哥伦比亚广播公司新闻助理项目成员。
查看完整简历
一家总部位于纽约的消费者保健公司正在召回近4万瓶眼药水，原因是对产品无菌性存在担忧。
根据美国食品药品监督管理局的一则公告， Prestige Consumer Healthcare已于7月29日启动此次召回，理由是“无法确保产品无菌”。
公告称：“此次召回是因为产品存在潜在污染风险。”
据产品介绍，本次召回的是15毫升装的Clear Eyes强效止痒眼药水，该产品可缓解眼部瘙痒、发红及其他眼部不适。该眼药水已在全美范围内分销。
根据美国FDA的定义，此次召回被列为二级召回，意味着该产品可能造成“暂时性或医学上可逆转的不良健康后果”。
Prestige Consumer Healthcare未立即回应置评请求。
召回信息
- 召回编号： D-0766-2026
- 批号： 2552A
- 有效期： 2027年9月30日
编辑：艾梅·皮奇
Clear Eyes eye drops recalled nationwide over contamination risk, FDA says
August 20, 2026 1:04 PM EDT / CBS News
By Mary Cunningham
Mary Cunningham is a reporter for CBS MoneyWatch. She previously worked at “60 Minutes,” CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program.
Read Full Bio
A New York-based consumer healthcare company is recalling nearly 40,000 bottles of eye drops over concerns about the product’s sterility.
Prestige Consumer Healthcare initiated the recall on July 29 due to “lack of assurance of sterility,” according to a U.S. Food and Drug Administration notice.
“The recall is due to potential contamination,” the notice says.
The recall affects 15mL bottles of Clear Eyes’ Maximum Itchy Eye Relief, which mitigates itchiness, redness and other eye irritations, according to the product description. The eye drops were distributed nationwide.
The FDA categorized the recall as Class II, which means a product could cause “temporary or medically reversible adverse health consequences,” according to the agency’s definition.
Prestige Consumer Healthcare did not immediately respond to a request for comment.
Recall info
- Recall number:D-0766-2026
- Lot code: 2552A
- Expiration date:September 30, 2027
Edited by Aimee Picchi
发表回复